Aclarion, Inc. (ACON)
NASDAQ: ACON · IEX Real-Time Price · USD
0.324
+0.018 (5.85%)
At close: Jul 26, 2024, 3:59 PM
0.330
+0.006 (1.79%)
After-hours: Jul 26, 2024, 5:41 PM EDT
Aclarion Market Cap
Aclarion has a market cap or net worth of $2.66 million as of July 26, 2024. Its market cap has decreased by -51.65% in one year.
Market Cap
2.66M
Enterprise Value
1.19M
1-Year Change
-51.65%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on April 22, 2022, Aclarion's market cap has decreased from $31.24M to $2.66M, a decrease of -91.49%. That is a compound annual growth rate of -66.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.50M | 38.89% |
| Dec 29, 2023 | 1.80M | -60.00% |
| Dec 30, 2022 | 4.50M | -85.59% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 2.69M |
| Qualigen Therapeutics | 2.65M |
| Altamira Therapeutics | 2.60M |
| Virax Biolabs Group | 2.60M |
| FOXO Technologies | 2.54M |
| Heart Test Laboratories | 2.50M |
| Entero Therapeutics | 2.48M |
| Cyclacel Pharmaceuticals | 2.46M |